跳至主要内容
临床试验/CTRI/2018/09/015714
CTRI/2018/09/015714招募中3 期

A randomised placebo control comparative study of 3 Curcumin formulations (1.Conventional Curcumin, 2.Self Nano emulsifying Curcumin, and 3.Curcumin with Piperine formulation) as an Add-on therapy in Hyperlipidemic human patients and evaluating their effect on the Lipid profile.

Self Sponsored0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patient able to provide written informed consent
  • 2. Patient of either sex of age 20 - 60 years (Both included)
  • 3. Diagnosed with Hyperlipidemia.
  • 4. Patient on Anti-hyperlipidemic drugs for at least 1 year.

排除标准

  • 1. Participants allergic /Sensitive to Turmeric, Curcumin or any of its derivative.
  • 2. Patient with very high Cholesterol level ( > 300 mg/dl)
  • 3. Patients diagnosed with a Cardiovascular disease.
  • 4. Patients diagnosed with Brain Tumors, Dementia, Depression, Parkinsonâ??s disease
  • 5. Concomitant treatment with other antidepressants, psychostimulants, or mood stabilizers, antiepileptic and antipsychotics.
  • 6. Presence of illicit drug and/or alcohol dependence.
  • 7. Pregnancy.
  • 8. Chronic disorders involving a vital organ (heart, lung, liver, kidney, brain) and congenital disorders.
  • 9. Malnutrition conditions (e.g., chronic diarrhea, inflammatory bowel disease) or lead poisoning.
  • 10. Chronic use of drugs affecting metabolism rate. (e.g., oral corticosteroids).
  • 11. Acute and Chronic Renal failure, hepatic disease, Stomach Ulcers

研究者

相似试验

To study the effect of 3 different formulations of... | 临床试验